金城医药：关于子公司参与全国药品集中采购拟中选的公告

Core Viewpoint - Jincheng Pharmaceutical announced that its wholly-owned subsidiary, Beijing Jincheng Tail Pharmaceutical Co., Ltd., and its holding subsidiary, Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., participated in the 11th national centralized procurement organized by the Joint Procurement Office, with plans to be selected for the procurement of Ribavirin tablets and Cefazolin sodium for injection [1] Group 1 - Jincheng Tail and Jincheng Jinsu are involved in the national drug centralized procurement bidding process [1] - The targeted products for procurement include Ribavirin tablets and Cefazolin sodium for injection [1]